ISATA BECKETT: Open Payments
NPI 1477227890 · CHATSWORTH, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$953 in 8 payments from 7 companies in 2025. Trend: 2023 $1,170 · 2024 $511 · 2025 $953
Food & beverage: $953
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 2 | $275 |
| Genentech, Inc. | 1 | $147 |
| Biogen, Inc. | 1 | $118 |
| MAYNE PHARMA COMMERCIAL LLC | 1 | $115 |
| Neurocrine BioSciences, Inc. | 1 | $114 |
| Axsome Therapeutics, Inc. | 1 | $101 |
| Otsuka America Pharmaceutical, Inc. | 1 | $82 |
Products named: REPATHA, Xolair, ZURZUVAE, ANNOVERA, INGREZZA, Auvelity, REXULTI.
Industry payments across CA — which companies pay providers there.
